Platelet and Plasma Market Set to Reach US$ 45.17 Billion by 2034
Advancements in blood component therapies, regenerative medicine, and transfusion practices are reshaping healthcare worldwide. Growing demand for platelet-rich plasma therapies and plasma-derived products continues to strengthen the industry’s long-term growth outlook. Increasing investments in healthcare infrastructure, improved donor recruitment initiatives. … Read more